| Autor: |
Selvakumar D; Centre for Heart Research, The Westmead Institute for Medical Research, The University of Sydney; Department of Cardiology, Westmead Hospital., Wilkie E; Centre for Heart Research, The Westmead Institute for Medical Research, The University of Sydney., Deshmukh T; Centre for Heart Research, The Westmead Institute for Medical Research, The University of Sydney; Department of Cardiology, Westmead Hospital., Ravindran D; Centre for Heart Research, The Westmead Institute for Medical Research, The University of Sydney., Kotake Y; Department of Cardiology, Westmead Hospital., Lu J; Department of Cardiology, Westmead Hospital., Barry T; Department of Cardiology, Westmead Hospital., Tran V; Department of Cardiology, Westmead Hospital., Paterson H; Sydney Imaging, Core Research Facility, The University of Sydney., Hing A; Department of Cardiothoracic Surgery, Liverpool Hospital., Campbell T; Department of Cardiology, Westmead Hospital., Kumar S; Department of Cardiology, Westmead Hospital., Kizana E; Centre for Heart Research, The Westmead Institute for Medical Research, The University of Sydney; Department of Cardiology, Westmead Hospital., Chong JJH; Centre for Heart Research, The Westmead Institute for Medical Research, The University of Sydney; Department of Cardiology, Westmead Hospital; james.chong@sydney.edu.au. |
| Abstrakt: |
Myocardial infarction is one of the leading causes of death and disability worldwide, and there is an urgent need for novel cardioprotective or regenerative strategies. An essential component of drug development is determining how a novel therapeutic is to be administered. Physiologically relevant large animal models are of critical importance in assessing the feasibility and efficacy of various therapeutic delivery strategies. Due to their similarities to humans in cardiovascular physiology, coronary vascular anatomy, and heart weight to body weight ratio, swine is one of the preferred species in the preclinical evaluation of new therapies for myocardial infarction. The present protocol describes three methods of administering cardioactive therapeutic agents in a porcine model. After percutaneously induced myocardial infarction, female landrace swine received treatment with novel agents through either: (1) thoracotomy and transepicardial injection, (2) catheter-based transendocardial injection, or (3) intravenous infusion via jugular vein osmotic minipump. The procedures employed for each technique are reproducible, resulting in reliable cardioactive drug delivery. These models can be easily adapted to suit individual study designs, and each of these delivery techniques can be used to investigate a variety of possible interventions. Therefore, these methods are a useful tool for translational scientists pursuing novel biological approaches in cardiac repair following myocardial infarction. |
